0001104659-19-048230.txt : 20190830
0001104659-19-048230.hdr.sgml : 20190830
20190830143212
ACCESSION NUMBER: 0001104659-19-048230
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190828
FILED AS OF DATE: 20190830
DATE AS OF CHANGE: 20190830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AKKARAJU SRINIVAS
CENTRAL INDEX KEY: 0001253170
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 191069186
MAIL ADDRESS:
STREET 1: 565 EVERETT AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: New York
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20031113
4
1
a4.xml
4
X0306
4
2019-08-28
0
0001270073
INTERCEPT PHARMACEUTICALS, INC.
ICPT
0001253170
AKKARAJU SRINIVAS
C/O INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, FLOOR 37
NEW YORK
NY
10001
1
0
0
0
Common Stock
2019-08-28
4
P
0
5207
60.32
A
403688
I
See footnote
Common Stock
21526
D
These purchases were executed in multiple trades at prices ranging from $60.01 to $60.32. The price reported above reflects the weighted average purchase price. Mr. Akkaraju hereby undertakes to provide full information regarding the number of shares and prices at which these purchases were effected, upon request, to the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer.
Shares held by Samsara BioCapital, L.P. ("Samsara BioCapital"). The reporting person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person's pecuniary interest therein.
/s/ Srinivas Akkaraju
2019-08-30